1. Academic Validation
  2. RP11-874J12.4 promotes oral squamous cell carcinoma tumorigenesis via the miR-19a-5p/EBF1 axis

RP11-874J12.4 promotes oral squamous cell carcinoma tumorigenesis via the miR-19a-5p/EBF1 axis

  • J Oral Pathol Med. 2020 Aug;49(7):645-654. doi: 10.1111/jop.13000.
Guo-Min Liu 1 2 Tian-Cheng Lu 2 3 Mao-Lei Sun 2 4 Xuan Ji 2 4 Yi-An Zhao 2 4 Wen-Yuan Jia 1 2 Yun-Gang Luo 2 4
Affiliations

Affiliations

  • 1 Department of Orthopedics, The Second Hospital of Jilin University, Changchun, China.
  • 2 Jilin Provincial Changbai Mountain Medicine Anti-Cancer Engineering Center, The Second Hospital of Jilin University, Changchun, China.
  • 3 Life Sciences College, Jilin Agricultural University, Changchun, China.
  • 4 Department of Stomatology, The Second Hospital of Jilin University, Changchun, China.
Abstract

Background: Oral squamous cell carcinoma (OSCC) ranks as the fifth most frequent Cancer worldwide, and the recurrence and migration of OSCC still pose large threats to patients. Long non-coding RNAs (lncRNAs) have recently emerged as crucial players in Cancer development, and it is of great significance to understand the regulatory nexus of lncRNAs in OSCC.

Methods: Here, we identified a novel lncRNA, RP11-874J12.4, which is ectopically expressed in OSCC and facilitates OSCC.

Results: RP11-874J12.4 directly binds to and regulates miR-19a-5p. Interestingly, RP11-874J12.4 and miR-19a-5p form a negative regulatory loop that inhibits the expression of miR-19a-5p in OSCC. The expression of an oncogenic transcription factor, EBF1, is unleashed in OSCC due to the low expression of miR-19a-5p, which promotes the growth and migration of OSCC.

Conclusion: Our data illustrate a regulatory axis of RP11-874J12.4/miR-19a-5P/EBF1 and an inhibitory loop with RP11-874J12.4 and miR-19a-5p. These data provide insights into the tumorigenesis of OSCC and the novel drug targets for OSCC.

Keywords

EBF1; OSCC; RP11-874J12.4; lncRNA; miR-19a-5p.

Figures
Products